Method for Screening Transglutaminase 2 Inhibitor or Activator

Details for Australian Patent Application No. 2005220231 (hide)

Owner National Cancer Center, Korea

Inventors Kim, See-Youl

Agent Wrays

Pub. Number AU-B-2005220231

Priority 10-2005-0052619 17.06.05 KR

Filing date 7 October 2005

Wipo publication date 11 January 2007

Acceptance publication date 16 December 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/573 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

Event Publications

20 October 2005 Complete Application Filed

  Priority application(s): 10-2005-0052619 17.06.05 KR

11 January 2007 Application Open to Public Inspection

  Published as AU-B-2005220231

16 December 2010 Application Accepted

  Published as AU-B-2005220231

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005220232-Apparatus for the electrostatic separation of particulate materials

2005220230-Treatment for periodontal disease